HKD 1.28
(4.92%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 28.57 Million USD | -41.1% |
2022 | 48.52 Million USD | 201.72% |
2021 | 16.08 Million USD | 5684.89% |
2020 | 278 Thousand USD | -64.08% |
2019 | 774 Thousand USD | -61.47% |
2018 | 2 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 21.42 Million USD | 0.0% |
2024 Q1 | 21.42 Million USD | -23.07% |
2023 Q2 | 42.7 Million USD | 0.0% |
2023 Q1 | 42.7 Million USD | -11.98% |
2023 Q4 | 28.57 Million USD | 0.0% |
2023 FY | 28.57 Million USD | -41.1% |
2023 Q3 | 28.57 Million USD | -33.09% |
2022 Q2 | 53.12 Million USD | 0.0% |
2022 FY | 48.52 Million USD | 201.72% |
2022 Q4 | 48.52 Million USD | 0.0% |
2022 Q3 | 48.52 Million USD | -8.65% |
2022 Q1 | 53.12 Million USD | 230.31% |
2021 Q4 | 16.08 Million USD | 0.0% |
2021 Q1 | 3.48 Million USD | 1152.16% |
2021 Q2 | 3.48 Million USD | 0.0% |
2021 Q3 | 16.08 Million USD | 361.99% |
2021 FY | 16.08 Million USD | 5684.89% |
2020 FY | 278 Thousand USD | -64.08% |
2020 Q4 | 278 Thousand USD | 0.0% |
2020 Q3 | 278 Thousand USD | -52.48% |
2020 Q2 | 585 Thousand USD | -99.81% |
2020 Q1 | 312 Million USD | 40210.85% |
2019 Q1 | - USD | 0.0% |
2019 Q3 | 203.03 Million USD | 0.0% |
2019 Q4 | 774 Thousand USD | -99.62% |
2019 FY | 774 Thousand USD | -61.47% |
2018 FY | 2 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 30.61 Million HKD | 6.644% |
CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 99.331% |